The Social Management of Genetic Engineering
Published on 23. July 1998
Book
Hardback
338 pages
978-1-85972-686-0 (ISBN)
Description
The emerging techniques in genetic engineering constitute a technological revolution with the potential to alter our environment and reconstitute animals and plants. This book presents recent work by European experts on moral philosophy, public policy, and the regulation and control of genetically controlled organisms. It sets out to articulate the key issues, controversies and possible solutions to the problems posed by genetic engineering and modern biotechnology. Areas covered include trangenic animals, xenografting, patenting life, human genome research, sustainable development, environmental release of genetically engineered organisms (GEO's), risk-assessment techniques and regulations. The book deals with the way this new technology can be democratized and "socially managed".
More details
Language
English
Place of publication
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
Professional and scholarly
Illustrations
figures, tables, indexes
Dimensions
Height: 157 mm
Width: 226 mm
ISBN-13
978-1-85972-686-0 (9781859726860)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
Content
Introduction, Peter Wheale; patrolling the boundaries or tracing the contours - cartographic metaphors and the human genome project, Peter Glasner; the European Community as an ethical actor? policy making on the human genome and the role of the European Parliament, Gabriele Abels; the UK human genome mapping project resource centre - a user analysis, Peter Glasner et al; how long is cooperation in genomics sustainable?, Pierre Joly and Vincent Mangematin; human genome research and the human genome diversity project - some ethical issues, Peter Wheale; DNA diagnosis and the emergence of cancer-genetic services in European health care, Pascale Bourret et al; from eugenics to therapeutics - the impact of opposition on the development of gene therapy in the USA, Paul Martin; some moral and legal implications of the new genetics for the foetus, Peter Wheale; the moral value of animals - philosophical and ethical considerations regarding modern biotechnology, Hub Zwart; xenografting as a subject for public debate, Medard Hilhorst; engineering acceptance - representation of "the public" in debates on biotechnology, Alison Hill and Mike Michael; useful models for biotechnology hazard identification - what is thing called "familiarity"?, Ad van Dommelen; democratizing the policy process for the environmental release of genetically engineered organisms, Rene von Schomberg; public policy and transgenic animals - case-by-case assessment as a moral learning process, Frans Brom et al; from animal welfare to intrinsic value - reconstructing public debates on animal biotechnology, Michiel Korthals and Elmar Theune; consensus conferences as participatory policy analysis - a methodological contribution to the social management of technology, Igor Mayor and Jac Geurts; the consequences of modern genetic engineering - patents, "nomads" and the "bio-industrial complex", Ruth McNally and Peter Wheale.